Literature DB >> 21656327

High circulating levels of interleukin-18 binding protein indicate the severity of glomerular involvement in systemic lupus erythematosus.

Chie Shimizu1, Takayuki Fujita, Yoshinobu Fuke, Ken Ito, Atsushi Satomura, Koichi Matsumoto, Masayoshi Soma.   

Abstract

In systemic lupus erythematosus (SLE), glomerular involvement often progresses with the activity of the disease. Immune complexes and abnormal secretion of cytokines are thought to be involved in the central mechanism of the development of lupus nephritis. We investigated serum levels of interleukin 18 (IL-18), a proinflammatory cytokine, and its natural antagonist IL-18 binding protein (IL-18 BP) in 45 patients with lupus nephritis. IL-18 levels were significantly increased in patients with Class II, Class III, and Class IV lupus nephritis compared with the level in a healthy control group. However, the levels stayed within the non-significant range in Class V. IL-18 BP levels were significantly increased in patients with Class III and Class IV lupus nephritis, in which histological activity and chronicity are severe. However, IL-18 BP levels stayed within the non-significant range in Class II and Class V, in which histological markers are mild. We also compared the levels of IL-18 and IL-18 BP in patients with and without glomerular infiltration of inflammatory cells. IL-18 was increased regardless of glomerular infiltration. However, IL-18 BP was increased only in patients with glomerular infiltration. These data suggest that IL-18 levels indicate the extent of the offending inflammatory response not only in the bloodstream but also in renal tissue, and that high IL-18 BP levels indicate the severity of existing glomerular injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21656327     DOI: 10.1007/s10165-011-0471-2

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  6 in total

1.  Deletion of IL-18 Expression Ameliorates Spontaneous Kidney Failure in MRLlpr Mice.

Authors:  Bastian Schirmer; Dirk Wedekind; Silke Glage; Detlef Neumann
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

2.  Serum IL-18 as biomarker in predicting long-term renal outcome among pediatric-onset systemic lupus erythematosus patients.

Authors:  Chao-Yi Wu; Huang-Yu Yang; Tsung-Chieh Yao; Su-Hsun Liu; Jing-Long Huang
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

Review 3.  Genetic and molecular biology of systemic lupus erythematosus among Iranian patients: an overview.

Authors:  Meisam Gachpazan; Iman Akhlaghipour; Hamid Reza Rahimi; Ehsan Saburi; Majid Mojarrad; Mohammad Reza Abbaszadegan; Meysam Moghbeli
Journal:  Auto Immun Highlights       Date:  2021-01-30

4.  Correlation between circulating interleukin-18 level and systemic lupus erythematosus: a meta-analysis.

Authors:  Mengmeng Xiang; Yang Feng; Yilun Wang; Jie Wang; Zhixiong Zhang; Jun Liang; Jinhua Xu
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

5.  Stronger Correlation between Interleukin 18 and Soluble Fas in Lupus Nephritis Compared with Mild Lupus.

Authors:  Mohammad Reza Hatef; Maryam Sahebari; Zahra Rezaieyazdi; Mohammad Reza Nakhjavani; Mahmoud Mahmoudi
Journal:  ISRN Rheumatol       Date:  2013-03-14

6.  Comparative effects of n-3, n-6 and n-9 unsaturated fatty acid-rich diet consumption on lupus nephritis, autoantibody production and CD4+ T cell-related gene responses in the autoimmune NZBWF1 mouse.

Authors:  James J Pestka; Laura L Vines; Melissa A Bates; Kaiyu He; Ingeborg Langohr
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.